{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Baltimore",
      "state": "MD",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA065129"
        ],
        "brand_name": [
          "CEFIXIME"
        ],
        "generic_name": [
          "CEFIXIME"
        ],
        "manufacturer_name": [
          "Lupin Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "68180-405",
          "68180-407",
          "68180-416",
          "68180-423"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "CEFIXIME"
        ],
        "rxcui": [
          "309058",
          "409823",
          "419849"
        ],
        "spl_id": [
          "735f86f4-369c-4f5a-adbe-7dacea2e27b4"
        ],
        "spl_set_id": [
          "6d68dbd9-7d75-4ff1-91db-79ff8ae879ec"
        ],
        "package_ndc": [
          "68180-405-01",
          "68180-407-03",
          "68180-407-04",
          "68180-416-08",
          "68180-416-11",
          "68180-423-11",
          "68180-423-08"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0368180423089",
          "0368180407034",
          "0368180416081",
          "0368180416111"
        ],
        "unii": [
          "97I1C92E55"
        ]
      },
      "product_type": "Drugs",
      "event_id": "94723",
      "recalling_firm": "Lupin Pharmaceuticals Inc.",
      "address_1": "Harborplace Tower",
      "address_2": "111 S Calvert St Fl 21st",
      "postal_code": "21202-6174",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the US",
      "recall_number": "D-0559-2024",
      "product_description": "Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03",
      "product_quantity": "3,552 bottles",
      "reason_for_recall": "Failed Content Uniformity Specifications",
      "recall_initiation_date": "20240530",
      "center_classification_date": "20240618",
      "termination_date": "20250429",
      "report_date": "20240626",
      "code_info": "Lot F201519, Expiry: November 2024"
    }
  ]
}